↓ Skip to main content

TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negat…

Overview of attention for article published in Breast Cancer Research, February 2020
Altmetric Badge

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
72 Mendeley